Long-term Trends in Upper Gastrointestinal Bleeding and Ischemic Outcomes after Myocardial Infarction
Clicks: 11
ID: 329841
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
3.0
/100
11 views
10 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #177 of 246 articles by views in european journal of preventive cardiology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 246 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Aims Invasive management and intensive antithrombotic regimens have decreased ischemic risk after myocardial infarction (MI) at the cost of more bleeding. Of particular concern is upper gastrointestinal bleeding (UGIB), which is both common and preventable, yet not well characterized over time. We aimed to describe trends of UGIB hospitalization in relation to other bleeding and ischemic outcomes as well as to explore associated clinical factors. Methods We included patients with acute MI enrolled in the SWEDEHEART registry discharged alive on antithrombotic treatment between 1999 and 2020. Patients were followed for hospitalization for adverse events at one year. Trends were analyzed in 2-year intervals for the overall cohort and subgroups. Standardized event rates for UGIB were calculated to assess the association of changes in demographics, comorbidities, in-hospital procedures and pharmacotherapy. Results Bleeding hospitalizations increased from 2.4% to 4.5%, peaking at 4.7% in 2013-14, while one-year MACCE decreased from 20.1% to 9.4%. The gastrointestinal tract was the most common bleeding site across all time intervals, with the majority of cases being UGIBs. Percutaneous coronary intervention, dual antiplatelet therapy, potent antiplatelet agents, and direct oral anticoagulants increased over time. Standardized event rates for UGIB suggest that changes in incidence were associated with evolving management strategies. Conclusion Bleeding hospitalizations after MI increased until 2013-14, with UGIB the most common source, while ischemic outcomes declined. These opposing trends were associated with the adoption of invasive management and intensified antithrombotic therapy. Routine tailoring of antithrombotic intensity and systematic gastroprotective measures should be considered in post-MI care.
| Reference Key |
openalex_W7214429289
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Jonatan Wärme, Moa Simonsson, Stefan Karl James, Lars Lindhagen, David Erlinge, Ole Fröbert, Joakim Alfredsson, Per Svensson, Tomas Jernberg, Robin Hofmann |
| Journal | european journal of preventive cardiology |
| Year | 2026 |
| DOI |
10.1093/eurjpc/zwag508
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.